Parexel expands Japanese offering; LabCorp teams up with Mitsubishi;

> Parexel ($PRXL) has expanded its Japanese post-market surveillance services to meet increasing regulatory standards in the country. News

> The U.K.'s Alacrita has teamed up with Debiopharm to help the Swiss company identify new compounds to buy and develop. Article

> INC Research has deepened its relationship with Medidata, becoming the IT outfit's most highly accredited partner. More

> Veeva Systems has launched a new eClinical platform it says can speed up clinical study. Item

> LabCorp's ($LH) clinical trial unit has signed a master service agreement with Mitsubishi. Story

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.